Patients live with the disease for decades and need increasingly complicated treatment regimens to attain glycemic goals. But other goals such as cardiovascular risk reduction, weight control, and avoidance of hypoglycemia also need consideration.
A new Cleveland Clinic-developed risk calculator helps patients with obesity and Type 2 diabetes understand and discuss with their physician the long-term risks of mortality and cardiovascular and renal morbidity, with and without bariatric surgery, allowing for a more informed treatment decision.
A large matched-cohort study in patients with type 2 diabetes and obesity finds that metabolic surgery confers significant improvements in all prespecified events plus marked reductions in weight, HbA1c, and use of diabetes and cardiovascular medications.
Should the primary focus of pre-diabetes treatment be glucose control or weight loss? Bartolome Burguera, MD, PhD, Chairman of Cleveland Clinic’s Endocrinology and Metabolism Institute, discusses the two different treatment scenarios.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Subanalysis of STAMPEDE trial data suggests the percentage of weight loss in the first year following surgery may be more important to diabetes management than weight fluctuations in the first five years.
Metformin should be considered in all adult patients with type 2 diabetes; gradual titration and extended release formulation should reduce adverse effects.
Defining intensification inertia as a unique phenomenon and exploring other barriers to the successful treatment of type 2 diabetes.
Metformin improves glycemic control without tending to cause weight gain or hypoglycemia, and should be considered in all adult patients with type 2 diabetes.
Attention digestive disease caregivers: enhance your patient care knowledge and learn about the latest critical topics at Cleveland Clinic’s 2018 Digestive Disease Nursing Symposium.
New research presented this week at the 16th World Congress of Endoscopic Surgery shows revisional surgery in patients with persistent or relapsed type 2 diabetes mellitus after bariatric surgery can significantly improve glucose control.